Engineers Gate Manager LP Mei Pharma, Inc. Transaction History

Engineers Gate Manager LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.42 - $0.65 $215 - $334	514 Added 3.75%	14,215 $9,000
Q1 2022 May 16, 2022	BUY	$0.54 - $2.74 $7,398 - $37,540	13,701 New	13,701 $8,000
Q3 2021 Nov 15, 2021	SELL	$2.52 - $2.99 $29,993 - $35,586	-11,902 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.6 - $3.65 $8,595 - $12,066	-3,306 Reduced 21.74%	11,902 $34,000
Q1 2021 May 17, 2021	BUY	$2.73 - $4.5 $41,517 - $68,436	15,208 New	15,208 $52,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $373M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.